References
- Kontoyiannis DP. Invasive mycoses: strategies for effective management. Am J Med. 2012;125:25–38.
- Hochart S, Barrier F, Durand-Joly I, Horrent S, Decaudin B, Odou P. Les antifongiques systémiques. Partie 2: éléments thérapeutiques. Pharm Hosp. 2008;43:155–68.
- Thiebaut A. Prophylaxie des infections fongiques invasives: nouvelles études cliniques. Hématologie. 2008;14:12–9.
- Aguerre C, Azzoug M, Adehossi A, Pelloquin N. Les nouveaux antifongiques. Monit Hosp. 2011;240:21–31.
- Andes D, Pascual A, Marchetti O. Antifungal therapeutic drug monitoring: established and emerging indications. Antimicrob Agents Chemother. 2009;53:24–34.
- Blanchet B. Suivi thérapeutique des médicaments antifongiques. Rev Fr Lab. 2004;365:39–47.
- Lass-Flörl C. Triazole antifungal agents in invasive fungal infections. Drugs. 2011;71:2405–19.
- Hussaini T, Rüping MJ, Farowski F, Vehreschild JJ, Cornely OA. Therapeutic drug monitoring of voriconazole and posaconazole. Pharmacotherapy. 2011;31:214–25.
- Summers KK, Hardin TC, Gore SJ, Graybill JR. Therapeutic drug monitoring of systemic antifungal therapy. J Antimicrob Chemother. 1997;40:753–64.
- Hope WW, Billaud EM, Lestner J, Denning DW. Therapeutic drug monitoring for triazoles. Curr Opin Infect Dis. 2008;21:580–6.
- Smith J, Andes D. Therapeutic drug monitoring of antifungals: pharmacokinetic and pharmacodynamic considerations. Ther Drug Monit. 2008;30:167–72.
- Verweij-van Wissen CP, Burger DM, Verweij PE, Aarnoutse RE, Brüggemann RJ. Simultaneous determination of the azoles voriconazole, posaconazole, isavuconazole, itraconazole and its metabolite hydroxy-itraconazole in human plasma by reversed phase ultra-performance liquid chromatography with ultraviolet detection. J Chromatogr B. 2012;887–888:79–84.
- Beste KY, Burkhardt O, Kaever V. Rapid HPLC-MS/MS method for simultaneous quantitation of four routinely administered triazole antifungals in human plasma. Clin Chim Acta. 2012;413:240–5.
- Gordien JB, Pigneux A, Vigouroux S, Tabrizi R, Accoceberry I, Bernadou JM, . Simultaneous determination of five systemic azoles in plasma by high-performance liquid chromatography with ultraviolet detection. J Pharm Biomed Anal. 2009;50:932–8.
- Alffenaar JW, Wessels AM, van Hateren K, Greijdanus B, Kosterink JG, Uges DR. Method for therapeutic drug monitoring of azole antifungal drugs in human serum using LC/MS/MS. J Chromatogr B. 2010;878:39–44.
- Decosterd LA, Rochat B, Pesse B, Mercier T, Tissot F, Widmer N, . Multiplex ultra-performance liquid chromatography-tandem mass spectrometry method for simultaneous quantification in human plasma of fluconazole, itraconazole, hydroxyitraconazole, posaconazole, voriconazole, voriconazole-N-oxide, anidulafungin and caspofungin. Antimicrob Agents Chemother. 2010;54:5303–15.
- Ng TK, Chan RC, Adeyemi-Doro FA, Cheung SW, Cheng AF. Rapid high performance liquid chromatographic assay for antifungal agents in human sera. J Antimicrob Chemother. 1996;37:465–72.
- Hubert P, Nguyen-Huu JJ, Boulanger B, Chapuzet E, Chiap P, Cohen N, . Harmonization of strategies for the validation of quantitative analytical procedures: a SFSTP proposal — part I. J Pharm Biomed Anal. 2004;36:579–86.
- Hubert P, Nguyen-Huu JJ, Boulanger B, Chapuzet E, Chiap P, Cohen N, . Harmonization of strategies for the validation of quantitative analytical procedures. A SFSTP proposal — part II. J Pharm Biomed Anal. 2007;45:70–81.
- Hubert P, Nguyen-Huu JJ, Boulanger B, Chapuzet E, Cohen N, Compagnon PA, . Harmonization of strategies for the validation of quantitative analytical procedures. A SFSTP proposal — part III. J Pharm Biomed Anal. 2007;45:82–96.
- International Organization for Standardization. General requirements for the competence of testing and calibration laboratories. ISO/IEC 17025. Geneva: International Organization for Standardization; 2005.
- International Organization for Standardization. Medical laboratories — particular requirements for quality and competence. ISO 15189. Geneva: International Organization for Standardization; 2012.
- Hulin A, Deguillaume AM, Bretagne S, Bézie Y. Bon usage des antifongiques dans le traitement des candidoses et aspergilloses invasives. J Pharm Clin. 2005;24:125–38.
- Schulz M, Schmoldt A. Therapeutic and toxic blood concentrations of more than 800 drugs and other xenobiotics. Die Pharm. 2003;58:447–74.
- Rozet E, Ceccato A, Hubert C, Ziemons E, Oprean R, Rudaz S, . Analysis of recent pharmaceutical regulatory documents on analytical method validation. J Chromatogr A. 2007;1158:111–25.
- Viswanathan CT, Bansal S, Booth B, DeStefano AJ, Rose MJ, Sailstad J, . Quantitative bioanalytical methods validation and implementation: best practices for chromatographic and ligand binding assays. Pharm Res. 2007;24:1962–73.
- Kobylińska M, Kobylińska K, Sobik B. High-performance liquid chromatographic analysis for the determination of miconazole in human plasma using solid-phase extraction. J Chromatogr B. 1996;685:191–5.
- Sanford JP, Gilbert DN, Chambers HF, Eliopoulos GM, Moellering RC, Saag MS. The Sanford guide to antimicrobial therapy 2010–2011. Belgian/Luxembourg edition. Bruxelles: SBIMC-BVIKM; 2010. p. 213.